Charles River Laboratories International, Inc. (CRL)
290.19
+3.36
(+1.17%)
USD |
NYSE |
Oct 02, 16:00
291.00
+0.81
(+0.28%)
Pre-Market: 20:00
Charles River Laboratories International Gross Profit Margin (Quarterly) : 36.29% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.29% |
| March 31, 2026 | 30.90% |
| December 31, 2025 | 30.96% |
| September 30, 2025 | 32.32% |
| June 30, 2025 | 30.82% |
| March 31, 2025 | 27.93% |
| December 31, 2024 | 27.77% |
| September 30, 2024 | 33.21% |
| June 30, 2024 | 32.69% |
| March 31, 2024 | 31.65% |
| December 31, 2023 | 33.23% |
| September 30, 2023 | 33.30% |
| June 30, 2023 | 34.41% |
| March 31, 2023 | 33.30% |
| December 31, 2022 | 33.05% |
| September 30, 2022 | 33.78% |
| June 30, 2022 | 32.74% |
| March 31, 2022 | 32.63% |
| December 31, 2021 | 35.06% |
| September 30, 2021 | 33.96% |
| June 30, 2021 | 33.75% |
| March 31, 2021 | 33.88% |
| December 31, 2020 | 34.47% |
| September 30, 2020 | 35.14% |
| June 30, 2020 | 30.34% |
| Date | Value |
|---|---|
| March 31, 2020 | 31.66% |
| December 31, 2019 | 34.93% |
| September 30, 2019 | 33.23% |
| June 30, 2019 | 32.79% |
| March 31, 2019 | 31.81% |
| December 31, 2018 | 34.58% |
| September 30, 2018 | 33.51% |
| June 30, 2018 | 33.50% |
| March 31, 2018 | 34.58% |
| December 31, 2017 | 31.92% |
| September 30, 2017 | 35.42% |
| June 30, 2017 | 37.01% |
| March 31, 2017 | 36.30% |
| December 31, 2016 | 35.29% |
| September 30, 2016 | 33.46% |
| June 30, 2016 | 36.04% |
| March 31, 2016 | 37.46% |
| December 31, 2015 | 37.26% |
| September 30, 2015 | 37.15% |
| June 30, 2015 | 36.94% |
| March 31, 2015 | 35.28% |
| December 31, 2014 | 34.30% |
| September 30, 2014 | 33.89% |
| June 30, 2014 | 35.13% |
| March 31, 2014 | 35.46% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 26.20% |
| Medpace Holdings, Inc. | 27.56% |
| Fortrea Holdings, Inc. | 17.63% |
| Champions Oncology, Inc. | 48.48% |
| Avantor, Inc. | 31.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.41% |
| Return on Assets | -3.15% |
| Return on Invested Capital | -3.93% |
| Profit Margin (Quarterly) | -0.08% |
| Operating Margin (Quarterly) | 14.96% |
| Return on Net Operating Assets | -3.51% |